Diabetes

The potentially deadly paradox of diabetes management

Diabetes affects nearly 1 in 10 adults in the U.S., of these millions, more than 90% have Type 2 diabetes. Controlling blood sugar and glycosylated hemoglobin levels—or HbA1c, which is sometimes referred to as A1C—is ...

Diabetes

Hemoglobin glycation index IDs harms, benefits of T2DM Tx

(HealthDay)—The effect of intensive versus standard type 2 diabetes treatment varies according to the hemoglobin glycation index (HGI: observed hemoglobin A1c [HbA1c] − predicted HbA1c), according to a study published ...

Diabetes

Group medicine appointments effective for glycemic control

(HealthDay)—Medical management delivered via group medical appointments (GMAs) appears to be effective for glycemic control in patients with type 2 diabetes, according to research published in the November issue of Diabetes ...

Diabetes

Daily text messages improve diabetes outcomes

(HealthDay)—Patients with poorly controlled diabetes have improvements in hemoglobin A1c and medication adherence and fewer trips to the emergency room after receiving daily text messages, according to a study published ...

Diabetes

Linear association for weight loss, HbA1c reduction in T2DM

(HealthDay)—For overweight and obese adults with type 2 diabetes (T2D), weight loss is associated with a reduction in hemoglobin A1c (HbA1c) in a dose-dependent manner, according to a review published online April 18 in ...

Diabetes

Adverse outcomes up with elevated HbA1c in late pregnancy

(HealthDay)—Elevated hemoglobin A1c (HbA1c) during the second and third trimesters correlates with increased risk of adverse pregnancy outcomes, according to a study published online Nov. 3 in Diabetes Care.

Diabetes

GLP-1 receptor agonists can manage postprandial glucose

(HealthDay)—Glucagon-like peptide 1 (GLP-1) receptor agonists appear beneficial for postprandial glucose management in type 2 diabetes, according to a report published in the October issue of Clinical Diabetes.

page 2 from 15